Completed

MLPS/LESSMicro-laparoscopic Versus Single-port Total Hysterectomy: a Randomized Trial.

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

micro-laparoscopy

+ Laparoendoscopic single site surgery

Procedure
Who is being recruted

Neurologic Manifestations+4

+ Pain

+ Pathologic Processes

From 18 to 75 Years
+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: May 2011
See protocol details

Summary

Principal SponsorCatholic University of the Sacred Heart
Last updated: August 16, 2012
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2011

Actual date on which the first participant was enrolled.

Between May 2011 and February 2012 a prospective randomized study was carried out at the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Catholic University of the Sacred Heart, Rome-Italy. Consenting patients scheduled to be submitted to a total laparoscopic hysterectomy for benign, pre-malignant and malignant disease were evaluated for this study. Inclusion criteria for total laparoscopic hysterectomy were: appropriate medical status for laparoscopic surgery; uterine size < 12 weeks of pregnancy; no previous longitudinal major abdominal surgery. Patients who had a pelvic organ prolapse greater than grade I, were excluded from this study. Pre-operative work-up included gynecologic examination, trans-vaginal ultrasound. In case of early endometrial and cervical cancer a staging MRI or CT was performed. Our institutional review board approved the study (Protocol number P/473/CE/2011), and all women gave their informed consent to use their data. All patients were adequately informed concerning the possible risks and benefits of the described technique and signed a written consent agreeing to undergo the procedure and to eventual conversion to LPS or laparotomy, if necessary. Patients were randomly assigned to either a hysterectomy with LESS or with M-LPS. The surgeon was notified of the allocation in theater on the morning of the procedure. The same surgical team performed both techniques. Assignment to one of the two surgical approaches was on 1:1, using a block randomized computer-generated list. The operative time (OT) was defined as the interval between start incisions to closure. The intra-operative complications was defined as bowel, bladder, ureteral, or vascular injuries, and the estimated blood loss (EBL) ≥ 500 ml. Anemia was considered when hemoglobin level was ≤ 8 g/dl and fever when body temperature was at least 38C° in two consecutive measurements at least 6 hours apart, excluding the first day after surgery. Post-operative pain assessment (in the immediate post-operative period) was performed in all patients using a validated Visual Analog Pain Scale (VAS) and scored from 0 to 10 (0 = no pain and 10 = agonizing pain). Post-operative pain was subjectively reported considering the patient at rest at 20 minutes and 2-4-8 hours after surgery. All patients were managed with the same intra-operative anesthetic protocol and post-operative analgesic drug (Paracetamol 1,000 mg) was administered only on patient's demand. LPS conversion was defined as single or multiple 5 mm port insertion. The perioperative complications were defined as those occurring within the first month following the procedure. Surgical Technique The operative technique is the same in the two groups with the exception of videoloparoscope, port type and some specific instruments. Once achieved pneumoperitoneum (12 mmHg), a careful inspection of the entire abdominal cavity was performed as first surgical step. All surgical procedures were performed with an intrauterine manipulator. After coagulation and section of round ligament to enter into the retroperitoneal space, the ureter was visualized and a haemostatic clip was positioned at the origin of the uterine artery. In order to safely cauterize and dissect the ovarian vessels, a window was opened between the left ovarian pedicle above and the ureter below. The vesico-uterine and vesico-vaginal peritoneum was dissected starting from the lateral to the medial. These surgical steps allow an excellent skeletonization of the uterine vessels, medially to the ureter along the uterus, which can be easily cauterizated and sectioned. The vagina was incised circumferentially following the porcelain-valve of the uterine manipulator as a guide. The uterus and the adnexa were extracted through the vagina. The vaginal vault was closed with a running suture. A hydro-pneumatic test for bladder integrity at the end of surgery was always performed. LESS hysterectomy was performed through a multi-channel single trocar (TriPort, Olympus Winter & Ibe GmbH, Hamburg - Germany) inserted in the umbilicus using an open technique (1.5-2 cm cutaneous incision), as previously reported (7). Intra-abdominal visualization was obtained with a 0° 5-mm telescope with a flexible tip (EndoEYE, Olympus Winter & Ibe GmbH, Hamburg - Germany). Working straight 5-mm instruments were inserted into the remaining 2 ports, choosing among graspers, cold scissors, suction/irrigation bipolar coagulator and a multifunctional versatile laparoscopic device, which grasps, coagulates and transects simultaneously (PKS cutting forceps, 43 cm, Gyrus ACMI, Hamburg, Germany). In order to prevent clashing between instruments and surgeon's hands and to facilitate surgical manoeuvres, the combination of one 33 cm-long instrument with a 43 cm-long instrument was adopted. The umbilical fascia was closed with a figure-of-eight 0-Vicryl. M-LPS hysterectomy was performed through one optical trans-umbilical 5 mm trocar (Endopath Xcel 5mm optiview, Ethicon Endo-Surgery, Cincinnati, OH) and three 3 mm sovra-pubic ancillary ports (Karl Storz Endoskope - 3 mm trocar set, Karl Storz, Tuttlingen, Germany). A 5 mm 0° endoscope (EndoEYE, Olympus Winter & Ibe GmbH, Hamburg - Germany) and 3 mm laparoscopic instruments (Karl Storz Endoskope - 3 mm Instrument Set, Karl Storz, Tuttlingen, Germany) were utilized, choosing among graspers, cold scissors, suction/irrigation and bipolar coagulator (PK 3mm, Gyrus ACMI, Hamburg - Germany). The present study is the first randomised one that directly compared M-LPS and LESS for total hysterectomy. We can argue that comparing two minimally invasive surgeries, variations are minimal and only a careful analysis can identify them. In our trial, we showed that there were no significant differences between the two techniques in terms of peri-operative outcomes except for OT that was longer in LESS with respect to M-LPS.As far as early post-operative pain is concerned, we found that patients undergoing M-LPS experienced significantly less pain with respect to those managed by LESS.

Principal SponsorCatholic University of the Sacred Heart
Last updated: August 16, 2012
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

71 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 75 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Neurologic ManifestationsPainPathologic ProcessesPostoperative ComplicationsSigns and SymptomsPathological Conditions, Signs and SymptomsPain, Postoperative

Criteria

3 inclusion criteria required to participate
appropriate medical status for laparoscopic surgery

no previous longitudinal major abdominal surgery

uterine size < 12 weeks of pregnancy

1 exclusion criteria prevent from participating
pelvic organ prolapse greater than grade I

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
M-LPS hysterectomy was performed through one optical trans-umbilical 5 mm trocar and three 3 mm sovra-pubic ancillary ports. A 5 mm 0° endoscope and 3 mm laparoscopic instruments were utilized, choosing among graspers, cold scissors, suction/irrigation and bipolar coagulator.

Group II

Active Comparator
LESS hysterectomy was performed through a multi-channel single trocar inserted in the umbilicus using an open technique (1.5-2 cm cutaneous incision), as previously reported. Intra-abdominal visualization was obtained with a 0° 5-mm telescope with a flexible tip.Working straight 5-mm instruments were inserted into the remaining 2 ports, choosing among graspers, cold scissors, suction/irrigation bipolar coagulator and a multifunctional versatile laparoscopic device, which grasps, coagulates and transects simultaneously. In order to prevent clashing between instruments and surgeon's hands and to facilitate surgical manoeuvres, the combination of one 33 cm-long instrument with a 43 cm-long instrument was adopted. The umbilical fascia was closed with a figure-of-eight 0-Vicryl.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Francesco Fanfani

Rome, ItalyOpen Francesco Fanfani in Google Maps
CompletedOne Study Center